With exposure to uv light bacteria and viruses in your bloodstream absorb five times as much photonic energy as do your red and white blood cells.
Iv laser therapy.
The patented control system that generates the mls pulse synchronizes the emissions to achieve optimum results.
Iv laser therapy is an innovative treatment from germany used to enhance healing from both acute and chronic conditions.
Mls laser therapy is a patented emission system created to achieve an efficient and simultaneous effect on pain contracture inflammation and edema within a short period of time.
Laser therapy is known to be very safe posing little risk for side effects especially compared to long term use of pharmaceuticals.
Class iv laser therapy now called photobiomodulation devices were cleared in 2004 by the fda for the safe and efficacious reduction of pain and increasing micro circulation.
Low level laser therapy or cold laser therapy is now referred to as photobiomodulation to better define treatments from specific lasers that are used for pain relief and healing.
Multiwave locked system mls class iv.
The majority of neuro musculoskeletal conditions respond better to a higher power and a higher dosage which is a function of power output and time dr.
What is class iv laser therapy.
Therapy lasers are safe and effective treatment options to reduce musculoskeletal pain and inflammation due to injury.
The practice was originally developed in the united states but most recent research on it has been conducted in germany by uv lamps and in russia in all variants.
Intravenous iv laser blood irradiation therapy is a procedure that exposes the clients blood to light to heighten the body s immune response and to kill infections.
Blood irradiation therapy is an alternative medical procedure in which the blood is exposed to low level light often laser light for therapeutic reasons.
Low level laser therapy has been tested for a wide range of conditions.
Laser therapy techniques vary based on the procedure.
It was first released in europe in 2005 after receiving research funding from the european union.